Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten U Vogel

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Plos One|January 23, 2023
Anti-neuraminidase and anti-hemagglutinin immune serum can confer inter-lineage cross protection against recent influenza BJoão Paulo Portela Catani, Tine Ysenbaert, Anouk Smet, et al.
Plos One|March 23, 2026
Internal gene segments from a mouse-adapted influenza B virus confer increased pathogenicity to miceArne Matthys, Laura Amelinck, Anouk Smet, et al.
NPJ Vaccines|January 22, 2026
Immunogenicity and protection of octavalent influenza vaccine candidates using adjuvanted proteins or mRNA-LNPs in naïve miceJoão Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, et al.
Plos One|January 31, 2022
Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cellsAnouk Smet, Joao Paulo Portela Catani, Tine Ysenbaert, et al.
Journal of Molecular Biology|April 22, 2026
Serum-antibody profiling of H3N2-infected ferrets using a combinatorial phage-display random peptide libraryTehila Yehudai, Gaik Tamazian, Lakshminarasaiah Uppalapati, et al.
Scientific Reports|April 14, 2016
Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategiesMichael Schotsaert, Tine Ysenbaert, Anouk Smet, et al.
Msphere|June 15, 2026
Immunization with N2 neuraminidase can protect mice against a heterologous influenza A virus challenge even in the absence of cross-NA inhibiting antibodiesLaura Amelinck, Anouk Smet, Tine Ysenbaert, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 23, 2013
Murine responses to recombinant MVA versus ALVAC vaccines against tumor-associated antigens, gp100 and 5T4David G Hanwell, Bryan McNeil, Lucian Visan, et al.
NPJ Vaccines|January 28, 2022
Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidaseJoão Paulo Portela Catani, Emma R Job, Tine Ysenbaert, et al.
The Journal of General Virology|December 26, 2001
Induction of anti-simian immunodeficiency virus cellular and humoral immune responses in rhesus macaques by peptide immunogens: correlation of CTL activity and reduction of cell-associated but not plasma virus load following challengeThorsten U Vogel, Brigitte E Beer, Jan Zur Megede, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Plos One|January 23, 2023
Anti-neuraminidase and anti-hemagglutinin immune serum can confer inter-lineage cross protection against recent influenza BJoão Paulo Portela Catani, Tine Ysenbaert, Anouk Smet, et al.
Plos One|March 23, 2026
Internal gene segments from a mouse-adapted influenza B virus confer increased pathogenicity to miceArne Matthys, Laura Amelinck, Anouk Smet, et al.
NPJ Vaccines|January 22, 2026
Immunogenicity and protection of octavalent influenza vaccine candidates using adjuvanted proteins or mRNA-LNPs in naïve miceJoão Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, et al.
Plos One|January 31, 2022
Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cellsAnouk Smet, Joao Paulo Portela Catani, Tine Ysenbaert, et al.
Journal of Molecular Biology|April 22, 2026
Serum-antibody profiling of H3N2-infected ferrets using a combinatorial phage-display random peptide libraryTehila Yehudai, Gaik Tamazian, Lakshminarasaiah Uppalapati, et al.
Scientific Reports|April 14, 2016
Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategiesMichael Schotsaert, Tine Ysenbaert, Anouk Smet, et al.
Msphere|June 15, 2026
Immunization with N2 neuraminidase can protect mice against a heterologous influenza A virus challenge even in the absence of cross-NA inhibiting antibodiesLaura Amelinck, Anouk Smet, Tine Ysenbaert, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 23, 2013
Murine responses to recombinant MVA versus ALVAC vaccines against tumor-associated antigens, gp100 and 5T4David G Hanwell, Bryan McNeil, Lucian Visan, et al.
NPJ Vaccines|January 28, 2022
Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidaseJoão Paulo Portela Catani, Emma R Job, Tine Ysenbaert, et al.
The Journal of General Virology|December 26, 2001
Induction of anti-simian immunodeficiency virus cellular and humoral immune responses in rhesus macaques by peptide immunogens: correlation of CTL activity and reduction of cell-associated but not plasma virus load following challengeThorsten U Vogel, Brigitte E Beer, Jan Zur Megede, et al.
Pageof 3